%PDF-1.3
%
86 0 obj
<>/OCGs[175 0 R]>>/Outlines 29 0 R/PageLabels 79 0 R/Pages 82 0 R/Threads 87 0 R/Type/Catalog>>
endobj
174 0 obj
<>/Font<>>>/Fields 179 0 R>>
endobj
83 0 obj
<>stream
Acrobat Distiller 7.0 (Windows)
3B2 Total Publishing System 8.06a/W
2014-07-11T10:46:19+01:00
2011-02-25T11:41:06+05:30
2014-07-11T10:46:19+01:00
application/pdf
Thomson
uuid:c591ec04-d57a-4826-9f82-75ce03ddf89f
uuid:fea2ed1f-96a9-4615-b1ac-8afd124a64c4
endstream
endobj
89 0 obj
<>
endobj
29 0 obj
<>
endobj
79 0 obj
<>
endobj
82 0 obj
<>
endobj
87 0 obj
[88 0 R]
endobj
88 0 obj
<>>>
endobj
108 0 obj
<>
endobj
109 0 obj
<>
endobj
90 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/TrimBox[34 34 620.803 816.394]/Type/Page>>
endobj
110 0 obj
<>
endobj
22 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/TrimBox[34 34 620.803 816.394]/Type/Page>>
endobj
111 0 obj
<>
endobj
112 0 obj
<>
endobj
113 0 obj
<>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/TrimBox[34 34 620.803 816.394]/Type/Page>>
endobj
114 0 obj
<>
endobj
115 0 obj
<>
endobj
116 0 obj
<>
endobj
117 0 obj
<>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/TrimBox[34 34 620.803 816.394]/Type/Page>>
endobj
118 0 obj
<>
endobj
119 0 obj
<>
endobj
120 0 obj
<>
endobj
121 0 obj
<>
endobj
122 0 obj
<>
endobj
123 0 obj
<>
endobj
124 0 obj
<>
endobj
125 0 obj
<>
endobj
126 0 obj
<>
endobj
127 0 obj
<>
endobj
128 0 obj
<>
endobj
129 0 obj
<>
endobj
130 0 obj
<>
endobj
131 0 obj
<>
endobj
189 0 obj
<>stream
q
0.96317 0 0 0.96317 12.061762 15.652566 cm
34.016 34.016 586.97 781.965 re
W n
1.0382383 0 0 1.0382383 -12.5229835 -16.2510938 cm
BT
0.31 0.31 0.31 rg
0 0 0 RG
0.193 w
/T1_0 12 Tf
2 Tr 0.9632 0 0 0.9632 81.6518 65.6392 Tm
(Copyright \251 Lippincott Williams & Wilkins. Unauthorized reproduction \
of this article is prohibited.)Tj
ET
q
0.96317 0 0 0.96317 12.0617618 15.6525657 cm
0.015 850.394 654.788 -850.379 re
W n
0 g
/GS0 gs
0.015 816.434 22.605 0.283 re
f
Q
q
0.96317 0 0 0.96317 12.0617618 15.6525657 cm
0 g
/GS0 gs
33.676 827.773 0.283 22.62 re
f
Q
q
0.96317 0 0 0.96317 12.0617618 15.6525657 cm
0 g
/GS0 gs
620.787 827.773 0.283 22.62 re
f
Q
q
0.96317 0 0 0.96317 12.0617618 15.6525657 cm
0 g
/GS0 gs
632.126 816.434 22.677 0.283 re
f
Q
q
0.96317 0 0 0.96317 12.0617618 15.6525657 cm
0.015 850.394 654.788 -850.379 re
W n
0 g
/GS0 gs
632.126 33.732 22.677 0.283 re
f
620.787 0.015 0.283 22.662 re
f
33.676 0.015 0.283 22.662 re
f
0.015 33.732 22.605 0.283 re
f
Q
q
0.96317 0 0 0.96317 12.0617618 15.6525657 cm
0 g
/GS0 gs
345.827 366.463 233.121 0.51 re
f
Q
BT
0 g
/GS0 gs
/T1_1 1 Tf
0 Tr 10.0754 0 0 10.0754 97.5731 738.6215 Tm
[(elimination)-851(b)23(y)-849(cytoto)29(xic)-845(T)146(-cell)-854(r)13(esponses.)-848(Se)10(v)29(eral)]TJ
0 -1.095 TD
[(differ)11(ent)-437(appr)21(oaches)-434(for)-427(each)-438(of)-440(these)-435(steps)-439(ha)21(v)35(e)-436(been)]TJ
T*
[(pr)20(oposed.)-213(F)11(or)-231(viral)-218(suppr)14(ession)-217(in)-212(the)-215(brain,)-214(the)-210(choice)-216(of)]TJ
T*
[(antir)11(etr)20(o)32(viral)-185(dr)-23(ugs)-184(should)-185(include)-186(those)-190(that)-183(ha)15(v)35(e)-186(the)-188(best)]TJ
T*
[(penetration)-368(into)-365(the)-362(brain)-366(and)-368(ar)13(e)-365(not)-365(neur)16(oto)30(xic)-363([21].)]TJ
T*
[(Fur)-20(ther)-408(it)-365(re)11(mains)-366(unkno)27(wn)-361(the)-367(extent)-364(to)-338(which)-363(these)]TJ
T*
[(dr)-18(ugs)-596(can)-593(pre)18(v)35(ent)-595(HIV)-595(re)11(plication)-598(in)-591(macr)17(ophages/)]TJ
T*
[(micr)23(o)11(glia)-248(and)-249(astr)20(ocytes.)-249(In)-247(general,)-244(it)-251(appear)-9(s)-245(that)-248(AR)97(Ts)]TJ
0 -1.1 TD
[(ar)13(e)-284(not)-284(as)-278(effecti)7(v)29(e)-278(in)-282(macr)22(ophages)-283([22])-282(and)-281(the)-280(effect)-285(of)]TJ
0 -1.095 TD
[(AR)97(Ts)-490(on)-494(HIV)-492(r)13(eplication)-492(in)-494(astr)20(ocytes)-492(has)-490(not)-490(been)]TJ
T*
[(explor)9(ed.)]TJ
0 -2.189 TD
[(Se)10(v)35(eral)-498(appr)21(oaches)-494(ha)21(v)29(e)-490(been)-485(used)-495(to)-495(re)11(activ)31(ate)-497(HIV)]TJ
0 -1.095 TD
[(infection)-500(\(r)12(ev)11(iew)43(ed)-499(in)-499([23]\).)-501(These)-499(include)-500(cytokines)]TJ
T*
[(such)-280(as)-284(IL-2)-285(and)-281(IL-7.)-285(Ho)32(w)29(e)14(v)29(er)33(,)-282(clinical)-284(tr)-43(ials)-273(with)-282(IL-2)]TJ
T*
[(and)-720(cAR)96(T)-569(or)-719(anti-CD3)-724(ha)21(v)35(e)-717(f)-23(ailed.)-722(IL-7)-719(appear)-9(s)]TJ
T*
[(pr)20(omising,)-358(as)-360(it)-359(can)-365(acti)13(v)18(ate)-356(both)-364(memor)-22(y)-339(and)-357(nai)10(v)29(e)-360(T)]TJ
T*
[(cells.)-524(Chemical)-521(compounds)-521(are)-515(being)-525(dev)45(eloped)-521(that)]TJ
T*
[(acti)13(v)18(ate)-221(pr)20(otein)-221(kinase)-225(C)19(,)-222(or)-242(transcr)-44(iption)-223(f)-17(actor)-12(s,)-224(n)11(uclear)]TJ
0 -1.1 TD
[(f)-23(actor-)]TJ
/T1_2 1 Tf
2.65 0 Td
(k)Tj
/T1_1 1 Tf
0.553 0 Td
[(B)-492(\(NF-)]TJ
/T1_2 1 Tf
3.165 0 Td
(k)Tj
/T1_1 1 Tf
0.553 0 Td
[(B\),)-488(and)-493(SP-1.)-488(One)-492(such)-491(compound,)]TJ
-6.921 -1.095 Td
[(pr)20(ostratin)-399(is)-403(being)-406(consider)9(ed)-402(for)-389(clinical)-403(tr)-43(ials.)-403(Se)10(v)29(eral)]TJ
0 -1.095 TD
[(compounds)-305(ar)13(e)-305(also)-311(being)-303(consider)9(ed)-304(that)-308(b)12(lock)-308(histone)]TJ
T*
[(deacytelase)-197(\(HD)86(A)32(C\).)-199(Ho)32(w)29(e)14(v)29(er)33(,)-201(r)13(ecent)-197(tr)-43(ials)-186(with)-201(v)24(alpr)20(oic)]TJ
T*
[(acid,)-310(a)-288(w)29(eak)-310(HD)82(A)32(C)-306(inhibitor)28(,)-309(ha)21(v)29(e)-311(not)-311(been)-312(successful.)]TJ
T*
[(Another)-203(compound,)-217(v)29(or)-41(inostat)-217(or)-225(suber)22(o)32(ylanilide)-221(h)21(ydr)22(o-)]TJ
T*
[(xamic)-510(acid)-515(\(SAHA\),)-512(is)-516(clinically)-493(appr)21(o)32(v)29(ed)-510(for)-503(cancer)]TJ
T*
[(therap)21(y)116(,)-211(is)-208(also)-208(a)-212(HD)82(A)32(C)-209(inhibitor)33(,)-211(and)-205(is)-213(being)-205(consider)9(ed)]TJ
T*
[(for)-400(such)-393(studies.)-391(Meth)18(yltransferase)-394(inhibitors)-402(and)-390(other)]TJ
T*
[(no)32(v)29(el)-316(compounds)-321(ar)13(e)-322(also)-322(being)-319(dev)45(eloped)-321(to)-316(reac)10(tiv)27(ate)]TJ
T*
[(HIV)169(.)-249(It)-254(is)-251(cr)-42(itical)-247(that)-253(befor)11(e)-251(these)-251(appr)21(oaches)-250(are)-244(applied)]TJ
0 -1.1 TD
[(to)-235(humans,)-236(their)-229(effects)-238(on)-234(central)-241(ner)-21(v)35(ous)-235(system)-238(\(CNS\))]TJ
0 -1.095 TD
[(r)13(eser)-25(v)35(oir)-9(s)-446(be)-440(studied.)-442(Reacti)11(v)24(ation)-447(of)-440(the)-432(vir)-23(us)-441(in)-439(the)]TJ
T*
[(brain)-252(could)-254(potentially)-257(ha)21(v)29(e)-257(de)16(v)18(astating)-254(consequences)-255(b)18(y)]TJ
T*
[(causing)-322(neur)22(onal)-326(injur)-25(y)116(.)-325(Ev)31(en)-322(in)-326(the)-324(pr)15(esence)-323(of)-326(cAR)96(T)124(,)]TJ
T*
[(early)-453(viral)-451(pr)26(oteins)-456(ar)13(e)-452(expected)-449(to)-452(be)-450(for)-42(med)-451(b)23(y)-448(the)]TJ
T*
[(pr)20(o)32(viral)-380(DNA,)-374(and)-384(within)-380(the)-378(brain)-382(these)-376(pr)20(oteins)-380(can)]TJ
T*
[(cause)-249(neur)22(onal)-250(injur)-19(y)-247(not)-251(only)-231(at)-246(the)-248(site)-249(of)-251(infection)-251(b)12(ut)]TJ
T*
[(also)-332(at)-333(distant)-335(re)11(g)-25(ions)-333([24,25].)]TJ
0 -2.189 TD
[(It)-341(is)-338(clear)-364(that)-340(the)-340(patient\325)93(s)-343(cytoto)29(xic)-341(imm)16(une)-344(r)13(esponses)]TJ
0 -1.095 TD
[(ar)13(e)-425(insuf\336cient)-421(to)-425(contr)21(ol)-422(the)-421(infection;)-424(hence)21(,)-423(se)13(v)29(eral)]TJ
0 -1.1 TD
[(appr)21(oaches)-185(are)-179(being)-189(pur)-13(sued,)-187(including)-188(the)-188(generation)-193(of)]TJ
0 -1.095 TD
[(T)-304(cells)-307(that)-308(w)29(ould)-307(encode)-302(T)146(-cell)-306(rec)10(eptor)-11(s)-310(der)-36(iv)40(ed)-304(fr)18(om)]TJ
T*
[(potent)-308(HIV)93(-speci\336c)-304(clones)-308(of)-310(cytoto)29(xic)-309(T)-304(cells.)-307(F)11(or)-328(this)]TJ
T*
[(strategy)-321(to)-327(be)-320(successful,)-319(it)-327(w)34(ould)-324(be)-320(impor)-24(tant)-324(that)-324(the)]TJ
T*
[(r)13(eper)-22(toir)11(e)-219(of)-213(T)146(-cell)-219(r)13(eceptor)-9(s)-218(include)-213(those)-217(that)-216(re)11(cog)11(nize)]TJ
T*
[(antigens)-292(expre)12(ssed)-291(in)-293(brain,)-295(as)-289(viral)-294(ev)38(olution)-290(ma)21(y)-264(occur)]TJ
T*
[(in)-461(this)-459(compar)-20(tment)-461(independent)-465(of)-462(lymphoid)-456(organs)]TJ
T*
[([16,17,26].)-364(Another)-371(strategy)-370(includes)-361(the)-367(inser)-18(tion)-365(of)-386(a)]TJ
T*
[(m)11(utation)-433(in)-439(the)-432(CCR5)-432(gene)-436(in)-434(patient\325)93(s)-435(T)-434(cells,)-432(thus)]TJ
T*
[(making)-675(them)-671(re)11(sistant)-679(to)-674(HIV)-671(infection.)-679(Although)]TJ
T*
[(r)13(epeated)-347(injections)-343(of)-348(these)-343(cells)-345(ma)21(y)-312(ev)43(entually)-349(re)11(place)]TJ
0 -1.1 TD
[(the)-432(T)-429(cells)-426(in)-434(the)-432(patient,)-428(it)-430(is)-430(unlik)18(ely)-428(to)-435(impact)-425(the)]TJ
0 -1.095 TD
[(cellular)-363(re)11(ser)-23(v)29(oir)-9(s)-332(in)-336(the)-334(brain.)]TJ
0 -2.189 TD
[(Another)-317(strategy)-310(is)-305(to)-305(incr)12(ease)-310(the)-307(n)11(umber)-286(of)-305(integ)-24(rated)]TJ
0 -1.095 TD
[(copies)-275(of)-278(HIV)-275(pr)20(o)32(viral)-278(DNA)-276(in)-277(a)-277(cell)-273(b)18(y)-274(dissociating)-280(the)]TJ
T*
[(Re)14(v-integ)-22(rase)-386(complex.)-385(The)-387(incor)-32(poration)-390(of)-386(m)11(ultiple)]TJ
24.573 62.429 Td
[(copies)-220(of)-218(HIV)-221(into)-219(the)-221(chr)17(omosomal)-220(DNA)-217(leads)-224(to)-219(death)]TJ
T*
[(of)-283(the)-286(cell.)-289(This)-284(strategy)-288(is)-283(based)-288(on)-282(the)-291(obser)-16(v)18(ation)-285(that)]TJ
T*
[(only)-545(one)-577(or)-599(tw)33(o)-580(copies)-578(of)-576(HIV)-579(pr)20(o)32(viral)-581(DNA)-575(get)]TJ
T*
[(integ)-18(rated)-304(in)-298(an)-299(infected)-305(cell)-300(despite)-297(the)-302(f)-23(act)-301(that)-302(a)-299(large)]TJ
T*
[(n)11(umber)-194(of)-218(uninteg)-24(rated)-217(copies)-215(of)-218(the)-215(DNA)-217(are)-206(pres)11(ent)-221(in)]TJ
T*
[(the)-194(cell.)-197(This)-197(is)-197(because)-196(the)-194(integ)-24(rase)-197(gets)-198(complex)32(ed)-196(with)]TJ
T*
[(Re)14(v)-594(and)-617(thus)-616(pr)15(ev)38(ents)-612(its)-616(activ)9(ity)114(.)-613(Dissociating)-617(this)]TJ
T*
[(complex)-261(allo)33(ws)-265(m)11(ultiple)-262(copies)-264(of)-261(HIV)-265(pr)26(o)27(viral)-261(DNA)-260(to)]TJ
0 -1.1 TD
[(get)-462(integ)-24(rated)-461([27].)-461(This)-463(strategy)-467(could)-460(potentially)-468(be)]TJ
0 -1.095 TD
[(effecti)13(v)29(e)-387(in)-391(a)-364(v)18(ar)-42(iety)-354(of)-391(cell)-387(types;)-387(ho)27(w)35(ev)43(er)28(,)-385(death)-388(of)-413(a)]TJ
T*
[(substantial)-218(n)11(umber)-194(of)-218(cells)-209(within)-217(the)-215(brain)-219(within)-217(a)-217(shor)-21(t)]TJ
T*
[(per)-41(iod)-389(of)-397(time)-389(could)-395(lead)-391(to)-392(disr)-25(uption)-391(of)-391(the)-394(blood)-73(\320)]TJ
T*
[(brain)-474(bar)-29(r)-41(ier)-477(with)-477(edema)-475(and)-476(impair)-41(ment)-476(of)-473(cer)10(ebral)]TJ
T*
(function.)Tj
0 -2.189 TD
[(Intensi\336cation)-691(of)-695(HAAR)96(T)-548(w)18(as)-690(one)-696(of)-695(the)-692(earliest)]TJ
0 -1.095 TD
[(strateg)-19(ies)-421(pr)26(oposed;)-419(ho)32(w)29(ev)43(er)28(,)-417(to)-419(date)-420(this)-415(has)-420(f)-23(ailed)-418(to)]TJ
T*
[(impact)-214(the)-215(r)13(eser)-19(v)29(oir)-9(s)-218([28].)-212(The)-214(a)21(v)24(ailability)-189(of)-213(new)38(er)-200(dr)-23(ugs)]TJ
T*
[(that)-270(target)-273(CCR5)-270(and)-270(integ)-24(rase)-273(has)-273(raised)-271(r)13(ene)12(w)29(ed)-272(hope)]TJ
0 -1.1 TD
[(for)-552(this)-529(appr)21(oach.)-528(Ho)27(w)35(ev)43(er)28(,)-531(for)-552(this)-529(appr)21(oach)-528(to)-533(be)]TJ
0 -1.095 TD
[(successful,)-449(it)-452(w)35(ould)-448(need)-453(to)-452(b)12(lock)-449(HIV)-449(r)13(eplication)-454(in)]TJ
T*
[(CNS)-723(re)11(ser)-23(v)35(oir)-14(s.)-722(Infection)-731(of)-727(glial)-729(cells)-724(can)-728(occur)]TJ
T*
[(independent)-443(of)-440(CCR5)-443([29])-445(and)-438(these)-446(cells)-442(ha)21(v)29(e)-441(large)]TJ
T*
[(amounts)-211(of)-218(uninteg)-19(rated)-217(vir)-17(us)-213([30])-217(that)-216(ma)21(y)-209(be)-217(capab)11(le)-213(of)]TJ
T*
[(for)-42(ming)-226(viral)-229(pr)20(oteins.)-228(Fur)-20(ther)31(,)-233(the)-226(duration)-232(of)-229(tr)12(eatment)]TJ
T*
[(w)34(ould)-210(need)-209(to)-213(tak)21(e)-208(into)-214(account)-211(the)-210(slo)31(w)-209(tur)-32(no)32(v)29(er)-238(rate)-213(of)]TJ
T*
[(glial)-388(cells)-377(within)-391(the)-389(brain.)-388(Initiation)-393(of)-386(HAAR)91(T)-385(soon)]TJ
T*
[(after)-485(infection)-440(ma)21(y)-442(decre)10(ase)-443(the)-443(estab)12(lishment)-444(of)-446(viral)]TJ
T*
[(r)13(eser)-19(v)29(oir)-9(s)-403([31];)-402(ho)27(w)34(ev)43(er)28(,)-401(its)-404(impact)-398(on)-407(CNS)-398(reser)-11(v)29(oir)-9(s)]TJ
T*
[(needs)-329(to)-338(be)-331(deter)-40(mined.)]TJ
/T1_3 1 Tf
11.9945 0 0 11.9945 345.1517 372.714 Tm
[(Suggestions)-337(for)-331(future)-339(directions)]TJ
/T1_1 1 Tf
10.0754 0 0 10.0754 345.1517 352.401 Tm
[(It)-379(is)-386(imperati)10(v)35(e)-381(that)-384(a)-385(better)-404(under)-10(standing)-380(of)-386(the)-372(viral)]TJ
T*
[(r)13(eser)-19(v)29(oir)-258(in)-223(the)-215(brain)-219(be)-217(achiev)41(ed)-217(in)-217(the)-221(antir)11(etr)20(o)27(viral)-218(era.)]TJ
T*
[(An)-315(estimate)-313(of)-321(the)-313(n)11(umber)-297(of)-316(cells)-318(infected)-316(in)-315(the)-318(brain)]TJ
T*
[(will)-393(be)-396(impor)-24(tant,)-395(as)-398(an)-396(imm)10(une)-398(attack)-394(against)-398(a)-396(large)]TJ
T*
[(n)11(umber)-232(of)-256(cells)-247(w)29(ould)-253(be)-244(v)29(er)-21(y)-253(detr)-43(imental.)-259(Unlik)23(e)-257(other)]TJ
T*
[(organs,)-248(the)-253(brain)-252(is)-251(encased)-250(in)-250(a)-250(bon)12(y)-253(ca)20(vity)-247(with)-255(little)-248(or)]TJ
0 -1.1 TD
[(no)-315(r)19(oom)-315(for)-308(expansion;)-317(hence)21(,)-320(an)10(y)-318(in\337ammation)-319(in)-315(the)]TJ
0 -1.095 TD
[(brain)-279(could)-282(lead)-282(to)-284(substantial)-283(brain)-284(injur)-19(y)116(.)-282(F)11(or)-274(example)20(,)]TJ
T*
[(acti)13(v)18(ated)-631(T)-635(cells)-632(can)-631(cause)-634(neur)22(onal)-635(injur)-25(y)-632(b)23(y)-632(the)]TJ
T*
[(extracellular)-228(r)13(elease)-197(of)-191(g)-25(ranzyme)-194(B)-194([32,33].)-193(Micr)23(o)11(glia)-199(and)]TJ
T*
[(astr)20(ocytes)-276(are)-271(long)-274(liv)40(ed)-277(with)-282(v)35(er)-21(y)-280(little)-281(tur)-32(no)32(v)35(er)-21(;)-282(hence)21(,)]TJ
T*
[(elimination)-363(of)-381(a)-364(signi\336cant)-362(n)11(umber)-340(of)-359(these)-365(cells)-361(could)]TJ
T*
[(ha)21(v)35(e)-268(pr)20(ofound)-272(effects)-270(on)-266(cer)10(ebral)-269(function.)-271(Nonetheless,)]TJ
T*
[(if)-370(an)-353(imm)10(une-mediated)-354(elimination)-352(of)-353(re)11(ser)-23(v)35(oir)-14(s)-348(in)-353(the)]TJ
T*
[(brain)-626(is)-630(to)-620(go)-627(forw)19(ar)13(d,)-633(then)-627(strateg)-19(ies)-632(need)-626(to)-631(be)]TJ
T*
[(dev)45(eloped)-234(for)-232(g)-20(radual)-230(elimination)-233(of)-234(the)-231(re)11(ser)-23(v)35(oir)-14(s.)-229(Anti-)]TJ
T*
[(in\337ammator)-18(y)-171(appr)21(oaches)-190(to)-197(b)12(lock)-189(the)-194(secondar)-18(y)-161(effects)-194(of)]TJ
0 -1.1 TD
[(cytoto)29(xic)-477(T)146(-cell-mediated)-479(neur)22(onal)-478(injur)-25(y)-475(need)-480(to)-479(be)]TJ
0 -1.095 TD
[(dev)45(eloped.)-575(In-vitr)21(o)-575(studies)-575(are)-569(needed)-572(to)-576(deter)-40(mine)]TJ
T*
[(whether)-246(cytoto)29(xic)-260(T)-261(cells)-258(can)-262(eliminate)-250(viral)-261(infection)-262(in)]TJ
T*
[(macr)22(ophages/micr)24(o)11(glia)-394(and)-395(in)-391(astr)20(ocytes.)-395(The)-393(di)12(v)29(er)-10(sity)]TJ
T*
[(and)-520(e)14(v)29(olution)-523(of)-521(the)-508(vir)-23(us)-517(in)-521(the)-524(brain)-517(needs)-519(to)-522(be)]TJ
T*
[(under)-10(stood,)-577(if)-581(w)35(e)-576(are)-569(to)-576(eng)-22(ineer)-582(T)-575(cells)-578(that)-579(will)]TJ
/T1_3 1 Tf
9.5957 0 0 9.5957 61.7522 766.5246 Tm
(578)Tj
ET
q
0.96317 0 0 0.96317 12.0617618 15.6525657 cm
88.441 776.579 32.712 0.454 re
f
Q
q
0.96317 0 0 0.96317 97.2454783 764.0674279 cm
0 0 m
490.507 0 l
490.507 -0.454 l
0 -0.454 l
f*
Q
BT
/T1_3 1 Tf
9.5957 0 0 9.5957 97.2454 766.5246 Tm
(AIDS)Tj
/T1_4 1 Tf
3.283 0 Td
[(2011,)-339(Vol)-339(25)-336(No)-334(5)]TJ
ET
/Artifact <>BDC
Q
q
1 0 0 1 554.8496094 811.5812378 cm
/GS1 gs
/Fm0 Do
Q
EMC
endstream
endobj
191 0 obj
<>>>/Resources<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
q
BT
0 g
0 i
/C2_0 10 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 0 -7.896 TD
<002F002C0037001100130013001400110017001B00170018>Tj
ET
Q
endstream
endobj
192 0 obj
<>
endobj
194 0 obj
<>
endobj
195 0 obj
[197 0 R]
endobj
196 0 obj
<>stream
H\j0 {b%mwD.x} MF1x38NxY=UZ9v5:蔖q^i' p)0er8TYvW9gJJ*=z6"(
^<*-_$8f(q2@YU@~`xn>="(
J#RFI'RF:t%HsPReҍTcZz\~8ATy(73_n+ c
endstream
endobj
197 0 obj
<>
endobj
198 0 obj
<>
endobj
199 0 obj
<>
endobj
200 0 obj
<>stream
Hj 0
endstream
endobj
201 0 obj
<>stream
H\Ut!H%D 1!lB<
%K $i)DRD@*
#ĶԂJ+ӻ=sg}|],DE=ӢJgA3-].xR]ԣsJ{k*̙tu@9 ƬV5⍘N (UMY?!^{)e>\52b+YZ8sU7.t;ېr90Hg/;ߙ'$baS">0-TY'Tu( y8WIeWsZ_ g
˷8x&{tohLjE.6a֣6Qdz--8Ʋc1ЉXZ($`Fh8uP{jNm/?ַ91"o8OerW0T?N<>(ɬ)ֲU[RT(1^c6YF>i\ׯG
xqE(uG?>#NFfdO17N7|#-Bm|䠞4ƈVl{3~d'"Eܪvt[H^+x8Rfb:M_1A,.j:iqOb*VanPUG-n:(ks!LO
1MD8-~v!Ɏ"Ke)
ҒG%ŤUTJVC5KmVecqnj[fk}g̞ee/?
ru=\$r/Vt/\P.WAų,b uX$^ߋ2Q&w:7xT:ȱgH/" e/,syj)rW!ex[NgWa+G)#5UG~%xJ|WT*4:F#IT+x!Nu#itsT*mYB
9[UQHU2LӋ0T Icȍv=4yw>}`8\C42}BqU]8mŢF[Hب+Q!Aw+Z:
7DS_Ebe)0Ez:"+s|Q~HM:OqQ*=#r݀Ϟ9$;Pϔja
h|vAп_>ԔYRb7WЃ]:;b;u@Lvm"#ۄmvyM+k$С{6[yX7$f/͒O2d]I63b]u,eиr]%u5!>y/\"fW\VʩOMASxY&͢#b¢)u[ܠLtʭQwng$5Ţ2DVrBf,[e1`ٔrؿ%ɑrx%}%An̗q?-YyL6K~]-)a|W$yylz%8dkbiǢlFN|.wp;ٴڸB#{ {\Nk`gW/KS.>ی$5)`ڶ{BAnX]d) .,3cY_㯄Uxcj`8~=_)c7.,6[Fl~R)P"zĴ
! JAu6&>r M
FH%MK+FULiЪ`_ߛ3o߾yof<7(U